Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 6 | 2009 | 459 | 0.900 |
Why?
|
| Sequence Analysis, DNA | 4 | 2009 | 80 | 0.580 |
Why?
|
| HIV Reverse Transcriptase | 2 | 2003 | 10 | 0.440 |
Why?
|
| HIV Protease | 2 | 2003 | 10 | 0.440 |
Why?
|
| Drug Resistance, Viral | 4 | 2009 | 43 | 0.420 |
Why?
|
| Genome, Viral | 1 | 2009 | 13 | 0.340 |
Why?
|
| Anti-HIV Agents | 3 | 2005 | 164 | 0.330 |
Why?
|
| Virus Diseases | 1 | 2008 | 16 | 0.300 |
Why?
|
| RNA Interference | 1 | 2008 | 34 | 0.300 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 66 | 0.300 |
Why?
|
| Antiviral Agents | 1 | 2008 | 135 | 0.270 |
Why?
|
| HIV Infections | 2 | 2009 | 890 | 0.240 |
Why?
|
| Virology | 1 | 2003 | 15 | 0.220 |
Why?
|
| Genotype | 5 | 2009 | 419 | 0.210 |
Why?
|
| Mutation | 3 | 2005 | 407 | 0.150 |
Why?
|
| Recombination, Genetic | 2 | 2009 | 12 | 0.140 |
Why?
|
| Phylogeny | 2 | 2009 | 69 | 0.140 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 244 | 0.140 |
Why?
|
| Democratic Republic of the Congo | 1 | 2009 | 2 | 0.090 |
Why?
|
| Sequence Homology | 1 | 2009 | 4 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 8 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2009 | 53 | 0.080 |
Why?
|
| Desiccation | 1 | 2009 | 5 | 0.080 |
Why?
|
| Blood | 1 | 2009 | 25 | 0.080 |
Why?
|
| Plasma | 1 | 2009 | 34 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2009 | 52 | 0.080 |
Why?
|
| Viruses | 1 | 2008 | 8 | 0.080 |
Why?
|
| Viral Proteins | 1 | 2008 | 24 | 0.080 |
Why?
|
| Proteins | 1 | 2008 | 73 | 0.070 |
Why?
|
| Templates, Genetic | 1 | 2005 | 2 | 0.060 |
Why?
|
| Codon | 1 | 2005 | 8 | 0.060 |
Why?
|
| Humans | 5 | 2009 | 30959 | 0.060 |
Why?
|
| Consensus Sequence | 1 | 2003 | 4 | 0.060 |
Why?
|
| Laboratories | 1 | 2003 | 26 | 0.060 |
Why?
|
| Quality Control | 1 | 2003 | 47 | 0.050 |
Why?
|
| Base Sequence | 1 | 2003 | 132 | 0.050 |
Why?
|
| Reference Standards | 1 | 2003 | 32 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2003 | 115 | 0.050 |
Why?
|
| International Cooperation | 1 | 2003 | 33 | 0.050 |
Why?
|
| Observer Variation | 1 | 2003 | 118 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 99 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 1 | 2002 | 96 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2003 | 1210 | 0.040 |
Why?
|
| pol Gene Products, Human Immunodeficiency Virus | 1 | 2009 | 2 | 0.020 |
Why?
|
| Humidity | 1 | 2009 | 4 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 74 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 158 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 166 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2009 | 162 | 0.020 |
Why?
|